A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients

Condition:   Edema Due to Heart Failure or Cirrhosis Intervention:   Drug: Spironolactone Oral Suspension Sponsor:   CMP Development, LLC Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials